Fine Foods & Pharmaceuticals N.T.M. SpA · MIL:FF
Fine Foods & Pharmaceuticals N.T.M. SpA — Q1 2022 Earnings Presentation
42 slides from Fine Foods & Pharmaceuticals N.T.M. SpA's earnings presentation, May 16, 2022
Slide 1: 3M-2022 Results Presentation
3M-2022 Results Presentation 16/05/22
Slide 2: Disclaimer
FINE FOODS 3M-2022 2 RESULTS PRESENTATION Disclaimer This document has been prepared by Fine Foods & The information contained in this document, unless Pharmaceuticals N.T.M. S.p.A. for the sole purpose otherwise specified is only current as of the date of this described herein. The information here
Slide 3: Fine Foods
FINE FOODS 3M-2022 3 RESULTS PRESENTATION Fine Foods We create value
Slide 4: Consolidated Financial Highlights
FINE FOODS 3M-2022 4 RESULTS PRESENTATION Q1-2022 Q1-2021 Consolidated REVENUES € 50.8 mln € 51.3 mln - 1.1% Financial EBITDA € 4.0 mln € 6.8 mln - 41.4% Highlights EBITDA MARGIN 7.8% 13.2% Q1-2022 Q4-2021 REVENUES € 50.8 mln € 50.0 mln + 1.5% EBITDA* € 4.0 mln € 2.3 mln + 69.9% figures reported in
Slide 5: Fine Foods I.D.
FINE FOODS 3M-2022 5 RESULTS PRESENTATION Fine Foods I.D. Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Euronext Star Milan, is an independent Italian Contract Development & Manufacturing Organisation (CDMO). It develops and manufactures finished products for the pharmaceutical, nutraceutica
Slide 6: Knowledge and technologies
FINE FOODS 3M-2022 6 RESULTS PRESENTATION Knowledge and → NUTRA AND PHARMA o Bottles technologies o Jars o Blister o Sachet Cross-fertilized innovation by exploiting our expertise in different fields and leveraging best practices and technical know-how to offer new tablets, capsules, granules, powde
Slide 7: Selection of products
FINE FOODS 3M-2022 7 RESULTS PRESENTATION Selection of products o Pharmaceuticals o Nutraceuticals o Cosmetics ➝
Slide 8: Customers' loyalty
FINE FOODS 3M-2022 8 RESULTS PRESENTATION 2010 Customers’ 2002 loyalty Retained key clients acquired before 2002 with several new ones added afterwards, including those derived from our recent acquisitions in the cosmetics industry, which consolidated our high customer retention rate. Note: Sigma-Ta
Slide 9: Fine Foods key figures
FINE FOODS 3M-2022 9 RESULTS PRESENTATION Fine Foods 192.6€m Revenues in 2021 with ~11% CAGR over the last 79.5€m increase in revenues over the last 5 years (63.3 key figures 10 years (~10% organic) organic) 2021 ~69% of products sold in ~264 customers, mainly leading 2021 has been delivered Pharmac
Slide 10: Fast growing Nutraceutical European Market
FINE FOODS 3M-2022 10 RESULTS PRESENTATION Fast growing EUROPEAN NUTRACEUTICAL PRODUCTION* (€bn) Nutraceutical CAGR European Market 4.6% 5.2% CAGR CAGR The European Nutraceutical Market 64.2 ’18-’21 ’21-’24 has shown high, steady growth, 56.1 and is expected to maintain a 48.2 18.5 Vitamins & Dietar
Slide 11: Pharmaceutical European production
FINE FOODS 3M-2022 11 RESULTS PRESENTATION Pharmaceutical EUROPEAN PHARMACEUTICAL EUROPEAN CDMOs (PHARMA) PRODUCTION * 2019 MARKET VALUE ** European production The European Pharmaceutical production is expected to continue its sound growth in coming 13% shows consistent years 23% non-cyclical (€bn)
Slide 12: Expanding in the fast-growing Cosmetic and Biocide market
FINE FOODS 3M-2022 12 RESULTS PRESENTATION Expanding in the EUROPEAN COSMETIC AND BIOCIDE MARKET fast-growing Cosmetic and The European Cosmetic and Biocide market is expected to accelerate growth in coming years Biocide market (€bn) CAGR 4.4% Source: Euromonitor International, 111 Consumer Health 2
Slide 13: Consistently outperforming Reference Markets
FINE FOODS 3M-2022 13 RESULTS PRESENTATION Consistently Reference markets show high steady growth and resilience during recessions Fine Foods has substantially outgrown its reference end-markets in the last decade, outperforming with 2021 sales at 2.9X the 2011 level Reference European Vitamins & Di
Slide 14: Research & Development
FINE FOODS 3M-2022 14 RESULTS PRESENTATION Research & Development
Slide 15: R&D for efficient and high-quality product development
FINE FOODS 3M-2022 R&D 15 RESULTS PRESENTATION R&D for efficient and high-quality product development Thanks to different approaches OPPORTUNITY LAB INNOVATION LAB CUSTOMISATION LAB TRANSFER LAB to each customer’s requests Formulae databank Innovative products Exclusive and Efficient Technology ➝ Hu
Slide 16: Environmental Social & Governance
FINE FOODS 3M-2022 16 RESULTS PRESENTATION Environmental Social & Governance
Slide 17: Strong holistic ESG approach since foundation
FINE FOODS 3M-2022 ESG 17 RESULTS PRESENTATION PEOPLE Strong holistic ESG approach since foundation ETHICS & ENVIRONMENT GOVERNANCE AREAS OF ACTION SUPPLY SUSTAINABLE CHAIN PRODUCTS LOCAL DEVELOPMENT ➝
Slide 18: Corporate Governance
FINE FOODS 3M-2022 ESG 18 RESULTS PRESENTATION ➝ ETHICS AND GOVERNANCE Corporate → 3 women out of 7 Directors Governance → 3 Independent Directors out of 7 Our governance is structured → 2 Non-executive Directors out of 7 around an ESG responsible approach. It allows us to pursue a sustainable growt
Slide 19: Ratings, ESG commitment, Certifications
FINE FOODS 3M-2022 ESG 19 RESULTS PRESENTATION ➝ ETHICS AND GOVERNANCE Ratings Sedex Member since ESG commitment Medium Risk 2016 (Business Units Food) Certifications Organizational, managerial and control models to prevent Since 2021 crimes Please note that each of the certifications Certificate of
Slide 20: Financials
FINE FOODS 3M-2022 20 RESULTS PRESENTATION Financials
Slide 21: Fine Foods Group Revenues
FINE FOODS 3M-2022 FINANCIALS 21 RESULTS PRESENTATION 51.3 50.8 Fine Foods Group - 1.1% Revenues Q1-2021 Q1-2022 Revenue break-down FOOD PHARMA COSMETIC 38.3 -22.9% 29.5 11.9 +18.6% +209.3% 10.0 9.4 3.0 Figures according to IAS-IFRS principles Q1-2021 Q1-2022 Q1-2021 Q1-2022 Q1-2021 Q1-2022 ➝
Slide 22: Fine Foods Group Revenues comparison
FINE FOODS 3M-2022 FINANCIALS 22 RESULTS PRESENTATION 50.0 50.8 Fine Foods Group + 1.5% Revenues comparison with Q4-2021 Q4-2021 Q1-2022 Revenue break-down FOOD PHARMA COSMETIC 31.8 29.5 -7.2% 11.9 +11.3% +24.8% 10.6 9.4 7.5 Figures according to IAS-IFRS principles Q4-2021 Q1-2022 Q4-2021 Q1-2022 Q4
Slide 23: EBITDA
FINE FOODS 3M-2022 FINANCIALS 23 RESULTS PRESENTATION EBITDA EBITDA margin decreased due to the current economic situation % of revenues that generated inefficiencies in the production chain and a significant 13.2% 7.8% increase in energy costs, which impacted more than 2% of the reduction in EBITDA
Slide 24: EBITDA comparison with Q4-2021
FINE FOODS 3M-2022 FINANCIALS 24 RESULTS PRESENTATION EBITDA comparison with Q4-2021 % of revenues Margins in Q1 2022 increased significantly compared to Q4 2021 due to the actions 4.7% 7.8% implemented by the Group +69.9% including the transfer of increased raw and packaging material costs to 4.0 c
Slide 25: EBIT
FINE FOODS 3M-2022 FINANCIALS 25 RESULTS PRESENTATION EBIT % of revenues EBIT decreased mainly due to the reduction in EBITDA and a slight increase in depreciation and amortisation for the period 7.1% 0.8% (+0.5 €m) 3.7 -88.8% 0.4 Figures according to IAS-IFRS principles Q1-2021 Q1-2022 ➝
Slide 26: Net income
FINE FOODS 3M-2022 FINANCIALS 26 RESULTS PRESENTATION % of revenues NET INCOME ADJUSTED 6.1% -4.9% Net income Net Income mainly affected by fair value 3.1 N/A evaluations (-2.5) Net Income 31.03.2021: Net Income 31.03.2022: o fair value evaluation o fair value evaluation * 1.3 €m Adjustments: positi
Slide 27: Healthy capital allocation
FINE FOODS 3M-2022 FINANCIALS 27 RESULTS PRESENTATION NET WORKING CAPITAL CAPEX AND INVESTMENTS NWC variance due to an increase in inventories In 2021 main impact derives from Pharmatek Healthy capital – caused by to the supply chain crisis management - and an increase in trade (Q1 2021) and Euro Co
Slide 28: Net Financial Position
FINE FOODS 3M-2022 FINANCIALS 28 RESULTS PRESENTATION Net MOST SIGNIFICANT CASH-IN AND CASH-OUT Financial NFP 2021 Net Income Amortization & Depreciation NWC Others CAPEX Buy Back NFP 31.03.2022 Position evolution from 2021 to 3M-2022 (15.7) (2.5) 3.6 (33.0) Figures according (15.4) 1.4 to IAS-IFRS
Slide 29: Shareholding structure
FINE FOODS 3M-2022 29 RESULTS PRESENTATION Shareholding structure
Slide 30: Shareholding structure
FINE FOODS 3M-2022 SHAREHOLDING STRUCTURE 30 RESULTS PRESENTATION FLOATING ON Shareholding Fine Foods Shares N. of shares (Mln) % LISTED SHARES structure Listed Shares Unlisted Shares 22.1 3.5 86% 14% As of 13.05.2022 Total Equity Capital 25.6 100% % OF TOTAL EQUITY CAPITAL % OF VOTING RIGHTS* 52.1%
Slide 31: Fine Foods shares
FINE FOODS 3M-2022 SHAREHOLDING STRUCTURE 31 RESULTS PRESENTATION Fine Foods Total Shares: 25,560,125 UNLISTED SHARES shares o Ordinary Shares – listed: 22,060,125 o Multiple Voting Rights Shares – unlisted: Multiple Voting Rights Shares: 3,500,000 3,500,000 o Totally owned by Marco Francesco As of
Slide 32: Fine Foods
FINE FOODS 3M-2022 32 RESULTS PRESENTATION Fine Foods Our way
Slide 33: Why Fine Foods?
FINE FOODS 3M-2022 33 RESULTS PRESENTATION o SOLID TRACK RECORDS Why Fine Foods? o HIGH AND STABLE o PHARMA FOOD o STRONG CAGR IN THE COSMETIC UNIQUE FINANCIALS LAST 10 YRS PRESENCE o CRITICAL o HOLISTIC MASS SUSTAINABILITY o CROSS FUNCTIONAL SINCE 2010 INNOVATIVE R&D o ADVANCED HR MANAGEMENT o LONG
Slide 34: contacts
contacts Fine Foods & Pharmaceuticals N.T.M. S.p.A. Investor Relations Tel. +39 035 4821382 ir@finefoods.it CDR Communication Media Relations Marianna Tremolada marianna.tremolada@cdr-communication.it 16/05/22
Slide 35: backup
FINE FOODS 3M-2022 35 RESULTS PRESENTATION backup
Slide 36: Manufacturing plants geographical footprint
FINE FOODS 3M-2022 36 RESULTS PRESENTATION BERGAMO Manufacturing ◎ plants FINE FOODS BREMBATE geographical footprint 1 ◎ FINE FOODS ZINGONIA ◉ 2 3 EURO COSMETIC MILAN ◎ TRENZANO ◉ HQ 4 1 Pharmaceuticals 2 Nutraceuticals 3 Cosmetics PHARMATEK CREMOSANO 4 Cosmetics – Biocides — Medical Devices ➝
Slide 37: Plants
FINE FOODS 3M-2022 37 RESULTS PRESENTATION ⦾Brembate ⦾Zingonia PHARMACEUTICAL NUTRACEUTICAL Plants 64.800 sqm of covered area COVERED AREA: COVERED AREA: on a Total area > TOTAL AREA: 26,100 sqm TOTAL AREA: 45,600 sqm ⦾Cremosano ⦾Trenzano COSMETICS COSMETICS COVERED AREA: COVERED AREA: TOTAL AREA: 9
Slide 38: People
FINE FOODS 3M-2022 ESG 38 RESULTS PRESENTATION ➝ PEOPLE WE HIRE People ~ 11.000 applications/year We are fully WOMEN SAFETY AT WORK committed to ~ 47% of total employees, o Management system for health ~ 48% of managers and safety is internationally creating an certified since 2014* environment with
Slide 39: Environment
FINE FOODS 3M-2022 ESG 39 RESULTS PRESENTATION ➝ ENVIRONMENT Environment We are committed to sustainably use our resources and reduce our environmental impact. CLIMATE WATER CIRCULAR ENVIRONMENT RESOURCES ECONOMY PROTECTION o - 11% CO2 emissions o Programs for o Programs for reduction of * o Install
Slide 40: Sustainable products
FINE FOODS 3M-2022 ESG 40 RESULTS PRESENTATION ➝ SUSTAINABLE PRODUCTS Sustainable We are able to offer Our production products certified biological and ecological cosmetic lines are certified to offer certified We are always researching, products. biological and/or testing and offering products natu
Slide 41: Suppliers' ESG management
FINE FOODS 3M-2022 ESG 41 RESULTS PRESENTATION ➝ SUPPLY CHAIN Suppliers’ ESG ENVIRONMENTAL AND SOCIAL ASSESSMENT OF OUR SUPPLIERS management value of purchases of raw materials and packaging from suppliers assessed by EcoVadis on ESG criteria Above Fine Foods ESG requirements Ongoing joint improveme
Slide 42: Relations with local communities
FINE FOODS 3M-2022 ESG 42 RESULTS PRESENTATION ➝ LOCAL DEVELOPMENT Relations MAIN COLLABORATIONS WITH UNIVERSITIES TRADE ASSOCIATIONS with local communities ➝
Fine Foods & Pharmaceuticals N.T.M. — Q1 2022 Earnings Presentation on 6ix